Community Practice Connections™: HPV: Points of Prevention in Primary Care

Release Date: November 23, 2020
Expiration Date: November 23, 2021

Activity Overview

Human papillomavirus (HPV) is responsible for more than 40,000 cases of cancer in the United States annually. Though HPV vaccines have been available for approximately 15 years, below-target vaccination rates for teens and recently expanded recommendations for adults create unmet needs in primary care. This Community Practice Connections™ program provides an in-depth review of some of the key highlights from an online virtual symposium held in October 2020. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of providing HPV vaccination, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the virtual meeting and to help reinforce learnings for those who did.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Merck Sharp & Dohme Corp.

Target Audience

This educational activity is directed toward family practice providers who treat patients who are candidates for HPV vaccination. Physicians, nurse practitioners, nurses, pharmacists, and other health care professionals interested in HPV vaccination are invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Review recommendations for HPV vaccination with patients and caregivers to increase informed decision-making
• Identify appropriate candidates for HPV vaccination, including the recently expanded group of patients aged 27 to 45 years
• Counsel patients and caregivers on the risks and benefits of HPV vaccination to reduce barriers to administration
• Discuss possible societal stigmas associated with HPV vaccination to improve vaccination confidence

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER^® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Chair

Margot Savoy, MD, MPH
Chair, Family and Community Medicine
Associate Professor, Family and Community Medicine
Lewis Katz School of Medicine
Philadelphia, PA

Disclosures: Author of the Immunizations chapter for Merck Manual.

Faculty

Linda M. Niccolai, PhD, ScM
Professor, Epidemiology of Microbial Diseases
Director, Connecticut Emerging Infections Program
Yale School of Public Health
New Haven, CT

Disclosures: Consultant: Merck & Co.

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Adult/Family Nurse Practitioner
Owner – Wright & Associates Family Healthcare
Amherst, NH

Disclosures: Consultant: GSK, Merck & Co, Pfizer, Sanofi - Vaccines, OA/Pain; Speaker’s Bureau: Allergan, Biohaven Pharmaceuticals, Merck & Co, Pfizer, Sanofi - Vaccines.

The staff of Physicians' Education Resource^®, LLC (PER^®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.